Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects

British Journal of Clinical Pharmacology

Volumn 63, Issue 2, 2007, Pages 206-215

  Shin, Jae Gook ^a,c   Kang, Won Ku ^a   Shon, Ji Hong ^a   Arefayene, Million ^c   Yoon, Young Ran ^a   Kim, Kyung Ah ^a   Kim, Doo Il ^b   Kim, Dong Soo ^b   Cho, Kwang Hyun ^b   Woosley, Raymond L ^c   Flockhart, David A ^c,d  

^a Inje University College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ethnicity; Gender; QT prolongation; Quinidine

Indexed keywords

QUINIDINE GLUCONATE;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG SENSITIVITY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HUMAN; KOREA; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADULT; ANTI-ARRHYTHMIA AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONG QT SYNDROME; MALE; QUINIDINE;

EID: 33846081056     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02793.x     Document Type: Article

References (34)

1. Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry 2001; 158: 1174-82.
2. Sale ME, Barbey JT, Woosley RL, Edwards D, Yeh J, Thakker K, Chung M. The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994; 56: 295-301.
3. Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther 2003; 10: 452-7.
4. Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q 2003; 74: 291-306.
5. Roden DM, Woosley RL. Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide. Pharmacol Ther 1984; 23: 179-91.
6. Roden DM, Woosley RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient care. Am Heart J 1986; 111: 1088-93.
7. Hohnloser SH, Van De Loo A, Baedeker F. Efficacy and proarrhythmic hazards of pharmacological conversion of atrial fibrillation: prospective comparison of sotalol vs. quinidine. J Am Coll Cardiol 1995; 26: 852-8.
8. Lee S, Harris ND, Robinson RT, Yeoh L, Macdonald IA, Heller SR. Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur J Clin Invest 2003; 33: 93-8.
9. Jouven X, Hagege A, Charron P, Carrier L, Dubourg O, Langlard JM, Aliaga S, Bouhour JB, Schwartz K, Desnos M, Komajda M. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 2002; 88: 153-7.
10. Mehta MC, Jain AC. Early repolarization on scalar electrocardiogram. Am J Med Sci 1995; 309: 305-11.
11. Vitelli LL, Crow RS, Shahar E, Hutchinson RG, Rautaharju PM, Folsom AR. Electrocardiographic findings in a healthy biracial population. Atherosclerosis Risk Communities (ARIC) Study Investigation. Am J Cardiol 1998; 81: 453.
12. Mansi IA, Nash IS. Ethnic differences in electrocardiographic intervals and axes. Electrocardiol 2001; 34: 303-7.
13. Liu XK, Wang W, Ebert SN, Franz MR, Katchman A, Woosley RL. Female gender is a risk factor for torsades de pointes in an in vitro animal model. J Cardiovasc Pharmacol 1999; 34: 287-94.
14. Bazett H. An analysis of the time relationship of electrocardiograms. Heart 1920; 7: 353-70.
15. Holford NH, Sheiner LB. Understanding the dose-effect relationship. Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6: 429-53.
16. Huet S, Bouvier A, Gruet MA, Jolivet E. Statistical tools for nonlinear regression. New York: Springer 1996, 69.
17. Olatunde A, Price Evans DA. Blood quinidine levels and cardiac effects in white British and Nigerian subjects. Br J Clin Pharmacol 1982; 14: 513-8.
18. Makita N, Horie M, Nakamura T, Ai T, Sasaki K, Yokoi H, Sakurai M, Sakuma I, Otani H, Sawa H, Kitabatake A. Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation 2002; 106: 1269-74.
19. Ma L, Lin C, Teng S, Chai Y, Bahring R, Vardanyan V, Li L, Pongs O, Hui R. Characterization of a novel long-QT syndrome mutation G52R-KCNE1 in a Chinese family. Cardiovasc Res 2003; 59: 612-9.
20. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: Implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc 2003; 78: 1479-87.
21. Ackerman MJ, Splawski I, Makielski JC, Tester DJ, Will ML, Timothy KW, Keating MT, Jones G, Chadha M, Burrow CR, Stephens JC, Xu C, Judson R, Curran ME. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: Implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004; 1: 600-7.
22. Aydin A, Bahring S, Dahm S, Guenther UP, Uhlmann R, Busjahn A, Luft FC. Single nucleotide polymorphism map of five long-QT genes. J Mol Med 2005; 83: 159-65.
23. Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT. Severe arrhythmia disorder caused by cardiac 1-type calcium channel mutations. Proc Natl Acad Sci U S A 2005; 102: 8089-96.
24. Iwasa H, Kurabayashi M, Nagai R, Nakamura Y, Tanaka T. Twenty single-nucleotide polymorphisms in four genes encoding cardiac ion channels. J Hum Genet 2002; 47: 208-12.
25. + channel gene KCNA5. Clin Pharmacol Ther 2005; 77: 138-44.
26. Anson BD, Ackerman MJ, Tester DJ, Will ML, Delisle BP, Anderson CL, January CT. Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels. Am J Physiol Heart Circ Physiol 2004; 286: 2434-41.
27. Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, Bhuiyan ZA, Wilders R, Mannens MM, Tan HL, Luft FC, Schunkert H, Wilde AA. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 2003; 59: 27-36.
28. Grandinetti A, Seifried S, Mor J, Chang HK, Theriault AG. Prevalence and risk factors for prolonged QTc in a multiethnic cohort in rural Hawaii. Clin Biochem 2005; 38: 116-22.
29. Liu XK, Katchman A, Drici MD, Ebert SN, Ducic I, Morad M, Woosley RL. Gender difference in the cycle length-dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 1998; 285: 672-9.
30. Lu HR, Marien R, Saels A, De Clerck F. Are there sex-specific differences in ventricular repolarization or in drug-induced early afterdepolarizations in isolated rabbit Purkinje fibers? J Cardiovasc Pharmacol 2000; 36: 132-9.
31. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 1996; 94: 1471-4.
32. Benton RE, Sale M, Flockhart DA, Woosley RL. Greater quinidine-induced QTc interval prolongation in women. Clin Pharmacol Ther 2000; 67: 413-8.
33. Merri M, Benhorin J, Alberti M, Locati E, Moss AJ. Electrocardiographic quantitation of ventricular repolarization. Circulation 1989; 80: 1301-8.
34. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690-5.